Literature DB >> 1737792

A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.

M Grigoriev1, D Praseuth, P Robin, A Hemar, T Saison-Behmoaras, A Dautry-Varsat, N T Thuong, C Hélène, A Harel-Bellan.   

Abstract

Oligonucleotide-directed triplex formation within upstream regulatory sequences is envisioned as a potential tool for gene inhibition. However, this approach requires that triple helix-forming oligonucleotides are chemically modified, so that the triplex is stable under physiological conditions. Here, we have compared several chemical modifications of an oligonucleotide, targeted to a natural 15-base pair homopyrimidine.homopurine sequence located in the upstream regulatory region of the gene encoding the interleukin-2 receptor alpha chain (p55, IL-2 R alpha). Methylation of the cytosines strongly stabilized the triplex. Further attachment of an intercalating agent (acridine) dramatically increased the stability of the triplex, as assessed by Tm measurements or by band shift assays. Furthermore, the acridine-derivatized oligonucleotide was more efficient in competing away high affinity DNA-binding proteins, as assessed by restriction enzyme inhibition assays. Using a novel footprinting assay, we have further shown that the interaction of the methylcytosine-substituted, acridine-derivatized oligonucleotide with a plasmidic target, harboring the IL-2 R alpha regulatory region, remains highly sequence specific, occurs at physiological pH and is independent of the superhelicity of the plasmid. Acridine derivatization did not impair the exquisite target specificity of triplex formation, since the derivatized oligonucleotide inhibited the binding of nuclear proteins to the overlapping NF kappa B enhancer sequence on an IL-2 R alpha target and not on the related human immunodeficiency virus long terminal repeat target. Finally, the oligonucleotide inhibited the NF kappa B-dependent tax-induced transcriptional activation of the IL-2 R alpha chloramphenicol acetyltransferase construct in live cells, whereas it did not have any effect on a human immunodeficiency virus long terminal repeat chloramphenicol acetyltransferase construct. We conclude that this modified oligonucleotide acts as a transcriptional repressor for the IL-2 R alpha gene via triple helix formation with regulatory sequences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737792

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Proton NMR studies of 5'-d-(TC)(3) (CT)(3) (AG)(3)-3'--a paperclip triplex: the structural relevance of turns.

Authors:  Laura B Pasternack; Shwu-Bin Lin; Tsung-Mei Chin; Wei-Chen Lin; Dee-Hua Huang; Lou-Sing Kan
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

Review 2.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

3.  Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides.

Authors:  J N Lampe; I V Kutyavin; R Rhinehart; M W Reed; R B Meyer; H B Gamper
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

4.  Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides.

Authors:  C Roy
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

Review 5.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

6.  Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats.

Authors:  S B Noonberg; J C François; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

7.  Detection of covalent triplex within human cells.

Authors:  A L Guieysse; D Praseuth; M Grigoriev; A Harel-Bellan; C Hélène
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

8.  Binding of DNA oligonucleotides to sequences in the promoter of the human bc1-2 gene.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.

Authors:  C Mayfield; D Miller
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.